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Abstract Phosphate-based glasses have been examined in
many studies as a potential biomaterial for bone repair
because of its degradation properties, which can be con-
trolled and allow the release of various elements to promote
osteogenic tissue growth. However most of these experi-
ments studied either tertiary or quaternary glass systems.
This study investigated a qinternary system that included
titanium dioxide for degradation rate control and zinc that is
considered to have a role in bone formation. Zinc and
titanium phosphate glass discs of different compositions
were melt synthesized and samples of each composition
was tested for different physical, chemical and biological
characteristics via density measurement, X-ray diffraction,
differential thermal analysis, mass loss, ion release, scan-
ning electron microscopy, biocompatibility studies via live/
dead assays at three time points (day 1, 4, and 7). The
results showed that the glass was amorphous and that the all
thermal variables decreased as zinc oxide amount raised,
mass loss as well as ion release increased as zinc oxide
increased, and the maximum rise was with ZnO15. The
cellular studies showed that all the formulation showed
similar cytocompatibility properties with MG63 except
ZnO15, which displayed cytotoxic properties and this was
conﬁrmed also by the scanning electron microscope images.
In conclusion, replacing calcium oxide with zinc oxide in
proportion less than 10 % can have a positive effect on bone
forming cells.
1 Introduction
Since the ﬁrst synthesis of Bioglass® by L.L.Hench in
1971, various glass compositions have been developed to be
examined for their suitability as biomaterials for clinical
application [1]. The concept behind bioactive glass was
their chemical reactivity and ability to form hydroxyl
crystalline apatite on the surface of the implanted material
[2]. Silicate-based glass has been used widely for hard and
soft tissue repair and many studies were done to explore the
use of silicate based glass for bone tissue engineering pur-
poses and found the ability of the silicate glass scaffolds to
enhance the cellular attachment and enhance both MC3T3-
E1 and osteoblast cell proliferation [3, 4]. However, whilst
melt derived Bioglass undergoes some initial degradation, it
is relatively insoluble [5, 6], which worked as a driver to
develop phosphate glass with its compositionally dependant
degradation rate. In addition the components making up a
phosphate-based glass may be biologically beneﬁcial to the
human body [3, 4]. The initial studies were concerned
mainly with simple ternary compositions composed of
phosphate, calcium oxide, and sodium oxide and that the
calcium played a major role in controlling degradation, as it
leads to the formation of non- bridging oxygen (P–O–Ca–
O–P) bonds that lead to structural and thermal stability of
the developed glass, concluding that the increase in calcium
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oxide percentages may reduce the degradation rate and
enhance the glass chemical durability [5, 6]. However, this
was followed by many studies that investigated the addition
of other various elements that can play a potential role in
hard tissue growth as well as enhancing glass properties
such as zinc and titanium.
Zinc is not only an essential element for cell growth,
proliferation, and differentiation, but it has an important role
in DNA replication, growth hormones, growth factors, and
enzyme production [7]. The human skeleton is usually
considered the main reservoir for zinc, which is mainly
stored in the osteoid layer [8, 9] It also has an inﬂuential
role on bone growth and mineralization through its ability to
activate aminoacyl-tRNA synthetase in osteoblastic cells, as
well as preventing resorption processes due to its inhibitory
action on osteoclasts [10, 11]. It was also found that zinc
containing bioactive glass has the potential property to form
hydroxy carbonate apatite layers on their surface after
soaking in simulating body ﬂuid [12]. Zinc phosphate-based
glass was originally developed to examine its physical and
biological effect on bioactive glass and was shown to
enhance osteoblast like cells (HOB) cell proliferation and
cellular attachment when it was added to ternary phosphate
glass at different oxide mole percentages which did not
exceed 5 mol % of glass composition [13]. Controversially,
it displayed poor biocompatibility on MG63 when it was
added to pyrophosphate glass in percentages between 10–
20 % as this amount of addition may lead to increased
degradation and decline in glass stability [13, 14]. Other
work concerned with studying the replacement of calcium
with zinc in silicate based glasses in different ratios (0.25,
0.5, 1, 1.5, 2.5, 5) mol % and revealed that zinc incor-
poration resulted in a lower degradation rate and enhance
glass durability, which does not show signiﬁcant results on
cellular physiological activities [15]. The addition of zinc
containing silicate glass to biphasic calcium phosphates,
which is composed of hydroxyapatite and β-tri calcium
phosphate showed a positive impact on rat calvarium-
derived osteoblasts cell proliferation and behavior [16].
Many studies have been performed to investigate the
effect of titanium addition to phosphate glass, and it was
found that titanium dioxide incorporation can aid in glass
stability and decrease the degradation rate and ion release
[17, 18]. It was found that an optimal percentage of titanium
dioxide is around 5 mol %, which has shown a biocompa-
tible effect on MG63 cell and the addition of titanium
dioxide above that amount does not have a clear and sig-
niﬁcant effect on glass degradation. The reason behind this
is that titanium may tend to make resistant covalent P–O–Ti
bonds instead of P–O–P that are more vulnerable to
hydration [19, 20], but because of the high valency of
titanium, there is a ﬁnite number of these bonds that can
form.
In the current study, different compositions of qua-
ternary and quinternary titanium stabilized zinc phos-
phate-based glasses were developed by the melt
quenching technique , with the titanium dioxide content
ﬁxed at 5 mol % in all the compositions and zinc oxide
was varied (0, 5, 10, and 15 mol %) in place of calcium
oxide content to investigate the impact of adding zinc
oxide on the physical and biocompatibility properties of
the glass and whether the effect of titanium dioxide
incorporation will decrease the degradation rate to offset
the increase seen when adding zinc oxide and therefore
overcome the deleterious effects of zinc incorporation that
was seen in the previous study [14].
2 Materials and methods
2.1 Glass preparation
Four different glass compositions of phosphate glass were
made by using phosphorus pentoxide (P2O5 98 %, VWR,
Lutterworth, UK), sodium dihydrogen phosphate
(NaH2PO4, 99 %, VWR), titanium dioxide (TiO2, 99 %,
VWR), calcium carbonate (CaCO3, 98.5 %, VWR) and zinc
oxide ( ZnO, 99.95 %, Sigma-Aldrich Gillingham, UK) as
precursors. The glass compositions were 50P2O5—10Na2O
—5TiO2—(35-x) CaO—x ZnO (mol %) where x (zinc
oxide) was 0, 5, 10, or 15mol%). The required amounts of
precursor powders were weighted according to proportions
by electronic balance (Sartorius) (Table 1) and blended for
1 min (Stomacher 400 blender/Seward). Once the mixing
has been ﬁnished, the precursor mixture was then placed
into a 200 ml volume Pt/10 %Rh crucible type 71040
(Johnson Matthey, Royston, UK) that was subsequently
placed in a furnace (Carbolite) at 1350 °C for 4 h. Following
this, the molten glass was then cast into a 420 °C preheated
graphite mold, which was placed again in a furnace for one
hour at 420 °C then left in the furnace to cool gradually to
room temperature overnight to remove the residual stress,
the 15 mm diameter glass rods were removed from the
mould and cut into 2 mm thick glass discs using a diamond
Table 1 Zinc phosphate glass composition
Zinc phosphate glass composition
Glass name and composition Amount (g)
P2O5 Na2O TiO2 CaO ZnO
ZnO 0% P50Na10Ti5Ca35 56.8 24 4 35 0
ZnO 5% P50Na10Ti5Ca30Zn5 56.8 24 4 30 4
ZnO 10% P50Na10Ti5Ca25Zn10 56.8 24 4 25 8.14
ZnO 15% P50Na10Ti5Ca20Zn15 56.8 24 4 20 12.21
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saw (Struers/ Accutom 50) and was checked it was amor-
phous using X-ray powder diffraction (XRD) analysis.
Glass was milled to make a powder of each of the com-
positions for XRD and Fourier transform infrared spectro-
scopy analyses (MM 301 Mixer Mill, Retsch GmbH, Hope,
UK).
2.2 Materials characterization
2.2.1 Density determination
The density of each composition was measured using an
analytical balance and density determination apparatus
according to Archimedes’ principal (AG 204 & MS-DNY-
43, Mettler Toledo, Beaumont Leys, UK). Ethanol was used
as the immersion ﬂuid since the phosphate glasses are
water-soluble. The density of the glass discs was calculated
using Eq. 1:
ρglass ¼
Mair
Mair Methanol ´ ρethanol
where ρglass is the density of the specimen (g/cm
3), ρethanol is
the density of ethanol at the temperature at which the
measurement was performed, Mair is the mass (g) of the
specimen in air and Methanol is the mass of the specimen
under ethanol.
2.2.2 Thermal analysis
Differential thermal analysis was performed for the four
compositions by using powder of each glass disc.
Three thermal parameters were measured: (1) Tg the
glass transition thermal temperature, (2) Tc the glass crys-
tallization temperature and (3) Tm the melting temperature.
A Setaram differential thermal analyzer was used in this
experiment using a nitrogen environment and heating tem-
perature extended from room temperature to 1400 °C at
20 °C min−1.
2.2.3 Material degradation
Triplicates of each composition were initially weighed then
stored in plastic vials (Sterilin tube) with 25 mm pre
adjusted pH deionized water to pH7 by (HCl or NH4OH)
and incubated at 37 °C. After 1, 4, 7, and 14 days, the
solution was removed and kept for ion release measure-
ments. While the glass discs were dried and weighed at each
time point to determine mass loss. Following weighing, the
discs were stored again in new fresh deionized water
solution.
2.2.4 Ion release measurements
Ion release measurement was performed for each stored
sample from the degradation study, this was done for the
anions (PO4
3−, P2O7
4−, P3O9
3−, P3O10
5−) and the cations
(Na+, Ca2+) and the transition metal (Zn2+) by using the ion
chromatography systems (ICS1000, ICS 2500, Dionex,
Thermo scientiﬁc, Hemel Hempstead, UK).
For the cation measurements all the samples were ﬁltered
prior to measurement to remove the anions (OnGuard II,
Dionex).
2.2.5 Cell studies
Initially, preparation of human osteoblast-like osteosarcoma
cell line (MG-63, European Collection of Cell Cultures,
Porton Down, UK) was done using standard conditions
(37 °C, 95 % air, 5 % CO2, 95 % relative humidity) in
Dulbecco’s modiﬁed Eagle medium (DMEM, Gibco, Life
Technologies, Paisley, UK) supplemented with 10% fetal
bovine serum (Gibco) and 1 % penicillin/streptomycin
(PAA Laboratories, GE Healthcare, Chalfont St. Giles,
UK).
Cell number Three discs of each composition were ster-
ilized by exposure to ultra-violet light for 10 min on each
side before being transferred to 24 well plates on which
cells were seeded evenly over the glass surface at a density
of 10000 cells per disc for 15 min to allow them to properly
attach to the discs then culture media was added to end up
with 1 ml of culture media for each glass discs. After that all
the samples were incubated at 37 °C in an atmosphere of
5 %CO2 for 7 days, Standard glass cover slides were used as
controls. Cell culture medium was replaced at 3 day peri-
ods. Live and dead assay was performed for all the com-
positions by using calcien AM (4 mM) as an indicator for
live cells and Ethidium homodimer-1 (2 mM) for dead cells.
This was performed by initial calibration for both of the
former reagents to gain the most appropriate molarity that
result in the optimal ﬂuorescent color, which was done by
seeding MG63 cells on glass slides discs and preparation of
various concentration of reagents as recommended by the
protocol, the best results were found with 1 µM calcien and
2 µM ethidium. At each time point, culture media was
removed and the cells were washed gently with Dulbecco’s
phosphate buffered saline. After the washing procedure,
3 mL of calcien and ethidium mixed solution was added to
each well plate and incubated for about 45 min. Following
that, the solution was removed and the samples were ready
for the cell counting under confocal (Bio-Rad, USA). The
cell counting was done on different 13 pre identiﬁed 1 mm
squares on each glass discs, these points were positioned on
15 mm circle template, which was made by transparent
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paper as is shown on (Fig. 1). Live and dead cells counting
was performed on three times points (day 1, day 4, and
day7) using the Image J software program.
Metabolic activity of cells Again triplicate discs of each
composition were sterilized as previously mentioned, before
being transferred to 24 well plates on which cells were
seeded at a density of 10,000 cells per disc in 1 ml of culture
media followed by incubation at 37 °C in an atmosphere of
5 % CO2 for 7 days. Cell culture medium was replaced at 3
day periods and the aspirated culture was kept in another 24
cell culture plate. cytocompatibility assay was done at three
times points (days 1, 4, and 7) in which a 10% solution of
water soluble tetrazolium salt-8 (alamar blue, ABD Serotec)
was added to the aspirated culture then stored in the incu-
bator for four hours at 5 % CO2. Alamar blue is a cell
viability assay reagent which contains the cell permeable,
non-toxic, and weakly ﬂuorescent blue indicator dye called
Resazurin, which is used as an oxidation-reduction (Redox)
indicator that undergoes colorimetric change in response to
cellular metabolic reduction. The reduced form Resoruﬁn is
pink and highly ﬂuorescent, and the ﬂuorescence produced
is proportional to the metabolic activity of cells and was
detected at 570 nm by a ﬂuorimeter (Inﬁnite M200, Tecan,
Männedorf, Switzerland).
Imaging of cells Scanning electron microscopy (SEM)
images were done at the same time points for each sample
which were ﬁxed initially in 3 % glutaraldehyde followed
by dehydration through a graded ethanol (50, 70, 90,
100 %) then drying by hexamethyldisilazane (Aldrich, UK).
2.3 Statistical analysis
Cell work data for both cell counting and metabolic activity
studies were statistically assessed by hierarchal ANOVA to
ﬁnd the statistical signiﬁcance between individual groups
and the differences were considered statistically signiﬁcant
at p o 0.05.
3 Results
3.1 Density measurement
Fig. 1 shows glass density (g cm−3) in relation to different
replacements of calcium oxides with zinc oxides and
revealed that density cumulate as the content of incorpo-
rated metal oxide increase, with densities ranging from 2.6
± 0.004 g cm−3 for zinc free quaternary glass to stand at
3.16± 0.03 g cm−3 for Zn15.
3.2 Thermal analysis
In contrast to the density measurements, all the thermal
parameters showed a decrease with increasing zinc oxide
content (Fig. 2). For the glass transition temperature Tg
which is considered an indicator for bulk glass properties, it
ranged from about 471 °C for the ZnO 0% to 407 °C for the
Zn 15 %, likewise the crystallization temperature was at
764 °C for ZnO 0% and decreased with increasing ZnO
glass to 720 °C for 15 mol % ZnO. The same pattern was
seen for the melting point in which it decreased with the
incorporation of zinc oxide, it extended between the wide
endothermic peak at 850 °C for the zinc oxide free glass to
about 793 °C for ZnO 15%.
3.3 Degradation study
Fig. 3 shows the cumulative mass loss per unit area mea-
sured (mg cm−2) over a 1 week period. There was
0
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ZnO0 ZnO5 ZnO10 ZnO15
Density
ZnO0 ZnO5
Fig. 1 Density of phosphate-based glasses with different CaO and
ZnO content. Cumulative zinc content resulted in increased glass
density from 2.6± 0.004 g cm−3 for ZnO0 to 3.16± 0.03 g cm−3 for
ZnO15, Error bars are SD (n= 3)
200 400 600 800 1000 1200
Temperature (.C)
Tg Tc Tm ZnO 15
ZnO 10
ZnO 5
ZnO 0
Fig. 2 Differential thermal analysis for the whole compositions in
which Tg represent glass transition temperature, Tc temperature of
crystallization and Tm is melting temperature. Showing that as zinc
incorporation increase all the thermal parameters decrease especially
the temperature of glass transition, which decreased gradually from
471 °C for Zn0% to 407 °C for Zn 15 %
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continuous mass loss over time for all the compositions but
the highest rate was in the compositions with higher zinc
oxide contents. In other words there was clear correlation
between Zinc percentage and mass loss rate. For all the time
points, the mass loss for ZnO 15% was about three times
that of Zn0 % and was about 0.46± 0.038 mg cm−2 for Zn
15 % in day 7 and about 0.16± 0.33 mg cm−2 for Zn 0 % at
the same time point. Both Zn5 % and Zn 10 % had similar
degradation rates at all the time points and was less than that
of Zn15 %.
3.4 Ion release measurement
Ion release results showed that anion and cation release
increased with zinc composition increment as it shown in
(Figs. 4, 5), respectively. Regarding the anions, ZnO 15%
displayed the highest release for all the anions, which was
signiﬁcantly higher than the other compositions. For the
other formulations (ZnO0, ZnO5, and ZnO10), although the
release was higher with the increased zinc composition, this
difference was not signiﬁcantly different. The cation release
trend was similar to that of anions and this was clear for
Zn2+, Ca2+, and Na+ in which cations release was sig-
niﬁcantly highest in ZnO15 and subsequently decreased as
the zinc ion proportion goes down. The only exception was
in Ca2+ release in which it was highest from the glass with
the highest calcium content which is ZnO0.
3.5 Cytocompatibility and metabolic activity
All glass compositions showed good cytocompatibility
except for ZnO15, and this was determined by the results of
the cell counting assay, which involved determination of
both live and dead cells from an initial seeding of around
10,000 cells/ disc. Concerning the live cells (Fig. 6a),
between seeding day and day 1, cells number approximately
doubled for control, ZnO0 and ZnO5 to reach about
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Fig. 3 Mass loss (mg cm−2) for the various four zinc phosphate based
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17,500 ~ 23,000 cells/disc this was signiﬁcantly more than
that of ZnO10 and ZnO15, which showed a lower rise in cell
density in both of them. By day 4, all the compositions dis-
played a further doubling to stand at about 40,000 ~ 55,000
cells/disc for control, ZnO0 and ZnO5, respectively, which
was again more than that of ZnO10 and ZnO 15 that were
about 30,000 cells/disc. For the last time point, cell numbers
were much higher, to reach around 100,000 ~ 125,000 for the
control and ZnO0 this was clearly signiﬁcant for the other
zinc containing glass (po 0.05).
Conversely and as expected, dead cells follow the
opposite pattern to that of live cells, in that dead cell
numbers rise as zinc percentage increases and was max-
imum for ZnO15 for all the days (Fig. 6b). By day 1, dead
cells number were about 160 ~ 400 cells/disc just half that
of ZnO15 that was about 800 cells/disc, which was
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(b)Fig. 6 Live and dead assay by
using Calcien for live cells and
ethidium iodine for dead. a
Accumulative counting for live
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signiﬁcantly higher than the other compositions. By day 4,
dead cells number increased by ﬁve times for all glass types
and was again signiﬁcantly different in ZnO15 to the other
types (p o 0.05). By day 7 dead cells number continued to
increase especially in the zinc containing glass with max-
imum number of non-viable cells was in ZnO15 samples
which was three times that of control samples.
Cell metabolic activity was determined by the alamar
blue assay (Fig. 7) in which the reduction of ﬂuorescence is
an indicator of metabolic activity. Metabolic activity
increased for all the formulations except ZnO15. At day 1,
Zn0 and Zn5 showed comparable values to that for the
control which was about 6± 1.2 % for control just slightly
higher than ZnO0 and ZnO5 activity , while both ZnO10
and ZnO15 showed low reduction ability, which was sig-
niﬁcantly different from control (p o 0.05). By day 4,
reduction rate for control increased three times to stand at
17± 0.4 %, which was signiﬁcantly different from ZnO0,
ZnO5, and ZnO10, However this statistical difference
cannot neglect the existence of increase metabolic activity
that happened in these glass formulations. Whereas ZnO15
show sign of signiﬁcancy with the other remaining groups
(p o 0.05).
The continuity in reduction percentage persists to day 7,
which was about 42± 3.3 % for control and was not as high
as that for ZnO0. Despite the presence of signiﬁcant dif-
ference between ZnO5 and Zn10 with the control, the mean
difference in reduction was little low from the control about
(6.5–9 %). Interestingly, reduction rate for ZnO15 showed a
clear decline in day 7 to end at 2.5± 0.7 % slightly higher
than that at day 1 and displaying higher signiﬁcant differ-
ence with the whole batches.
SEM images (Fig. 8) showed that MG63 cells have
attached to all glass compositions at all time points. After 1
day, the cells seemed to spread around the glass surface and
they took an irregular shape. However, the cells on ZnO15
tended to be smaller. On day 4, the cells could be seen to
have connected to each other with the appearance of
rounded and swollen nucleus, some cells showed long-
itudinal shape that may be due to cell division. By day 7,
cells were evenly distributed over the surface. Moreover,
there was a clear increase in cell numbers, which were
mostly interconnected with each other forming a semi-
complete cellular layer. The only exception was in ZnO15
in which there was a low number of cells which were small
in size and separated from each other.
4 Discussion
The present study concerned with the development of dif-
ferent phosphate-based glasses for hard tissue (bone) engi-
neering applications, and this was done by substituting the
calcium oxide with zinc oxide, since zinc is known to play
important roles in the bone metabolism and development
[21]. Previous studies have been carried out to assess dif-
ferent zinc phosphate glass properties, these studies asses-
sed (P2O5–Na2O–CaO–ZnO) phosphate glass and showed
that these compositions suffered from poor cytocompat-
ibility due to their rapid degradation rate and this rate
increased with increasing zinc addition [13, 14]. Other
studies were performed with the incorporation of various
amount of titanium dioxide to the tertiary based glass to
improve its cytocompatibility and enhance its durability.
titanium dioxide was added at 3 mol %, 5 mol %, 7 mol %
and revealed that as titanium dioxide increased, the degra-
dation rate and ion release rate decreased. Also the 5 mol %
titanium dioxide containing glass showed the most favor-
able cytocompatibility results in comparison to the titanium
dioxide free control samples [22] and this was the main
rationale for the selection of this titanium dioxide content in
the present study.
The thermal properties reduced with incorporation of
zinc oxide and this tends to be as a result of the fact that zinc
oxide bond enthalpy is about 284 Kj/mol, which is less than
that of calcium oxide bond 464 Kj/mol as a result of this
less energy is needed to break the zinc oxide bond.
Usually the main factors that control degradation of
material are the atom size, bond length and electronegativity
of bond. Although both of Zn–O and Ca–O bonds have
pure ionic bonds [23, 24] as the difference in electro-
negativity of both Zn–O and Ca–O are more than 2, Ca–O
seems to be more electronegative (3.44−1= 2.44) than that
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Fig. 7 Alamar blue assay showing ﬂuorescence reduction percentage,
which is an indicator for metabolic activity. The maximum reduction
was in TCP in (1, 4, 7 days), which is insigniﬁcantly different from
ZnO0, ZnO5, and ZnO10. Zn15 had the lowest rate of ﬂuorescence
reduction. Error bars are SD (n= 3), while * is signiﬁcant difference
(p o 0.05)
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of Zn-O (3.44−1.65= 1.79) when 3.44, 1.65, and 1 are the
electronegativity of O, Zn, and Ca, respectively. As a
consequence, Ca–O has more bond polarity and bond
strength of Zn–O, which may explain the glass suscept-
ibility to degradation as zinc percentage increase that could
affect the whole glass compositional structure and resulted
in this pattern of weight loss (ZnO0 o ZnO5 o ZnO10
o ZnO15).
The ion release results were concurrent with the weight
loss pattern. It was found that the increase of phosphate
anion release increased as the zinc oxide content increased,
this may be due to the effect of weak Zn–O–P bond. For the
cation release it took the same trend for Na+ and Zn+2 ions,
the only exception was for Ca+2 ions, which was released at
higher levels in the glass with ZnO 0 mol % glass and this
result was the opposite to the other ions, but that can be
explained by the fact that as the ZnO content decreased, the
CaO content increased. however the general information
that was obtained from zinc oxide containing glass ion
release was that there was a gradual release in all the ions
with time which was similar for the compositions ZnO0, 5,
10 mol %, but the release for the ZnO15 mol % was higher
and both ﬁndings OD mass loss and ion degradation were
consistent with that of Salih et al. [13].
Concerning cell studies, live and dead assay was per-
formed by using a template. Previous work was done by
subjective image visualization, whereas the main aim in the
current study was to objectively determine the real number
of cells by using a template. The template was designed to
ﬁt the glass discs perfectly (diameter= 15 mm) and was
divided into small (1 × 1 mm) squares to facilitate cell
counting readings. Only 13 pre chosen squares per each
sample were selected for the measurements. Although the
total area of these squares constituted only 7 % of the whole
Day 1 Day 4 Day 7
ZnO 0
ZnO 5
ZnO 10
ZnO 15
Fig. 8 Scanning electron microscope images
157 Page 8 of 11 J Mater Sci: Mater Med (2016) 27:157
disc area, their positions were selected in a way that ensure
the full distribution over the whole central area of the disc to
prevent repeating readings and give a valid picture of cell
distribution over the disc since each of the selected squares
was surrounded by non-interpreted squares. Cell seeding
was performed with caution to ensure the even cell dis-
tribution for all the samples and this was by preparation of
the intended cell density in 50 µl of culture media which
was found to be the optimum media volume to cover the
whole disc surface area. The ﬁndings of this study showed
that live cell number was insigniﬁcantly different between
ZnO0 and ZnO5 and the control sample for all time points,
it is increased in about the same rate and even if there was
slight signiﬁcant difference in some time points, this does
not cancel the positive impact of these two compositions on
cells proliferation. Conversely, cell number was clearly low
in ZnO15 and ZnO10 and was signiﬁcantly different from
the control group and they have about half the cell number
of the control samples , this was furtherly conﬁrmed by the
results of the dead cell count which was linked to zinc oxide
Day 1 Day 4 Day 7
a
b
c
d
e
dead cells 
Live cells 
Fig. 9 Live and dead images by using confocal. Live looks green while dead are red in color. a control, b ZnO 0, c ZnO5, d ZnO 10, e ZnO15
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content (ZnO154 ZnO104 ZnO54 ZnO04 control)
and this showed that the high dissolution glass gave poorer
cell data, and for ZnO15 dead cells numbers constitute
about 10 % of live cell numbers on the same day for the all
time points which indicates cytotoxicity (Fig. 6, Fig. 9).
Alamar blue measurements, is the indication of reduction–
oxidation reaction (Redox) reaction as the viable metabolic
cells tend to form reduced environment, which can reduce
the weakly ﬂuorescent resazurin salt to strongly ﬂuorescent
resoruﬁn [25]. The data were concurrent with that of live
and dead cells as it displayed that Zn15 have very low
impacts on MG63 metabolic activity and were with highly
signiﬁcant difference in comparison to the other glass for-
mulations at all time points. Despite there was little differ-
ence between ZnO10 and the control sample, it showed
high metabolic activity within time. ZnO0 and ZnO5
appeared to have lower levels of effect on metabolic activity
compared to the control samples and these results matched
that of live cells and had the pattern of (control4 ZNO04
ZNO54 ZnO104 ZnO15). Despite the presence of sta-
tistical difference (p o 0.05) between the control and Zn0
and Zn5, there was evidence of metabolic activity
enhancement in the previously mentioned glass composi-
tions which may indicate their benign effect on cellular
activity. SEM images emphasized the previous ﬁnding and
showed differences in cell number for Zn15 and a decline in
cellular interconnection. These outcomes may be due to the
high rate of degradation in ZnO 15%, which lead to high
Zinc release which could play an unwanted impact on cell
proliferation by suppression the expression mRNa as was
found in previous studies [26, 27] . Interestingly, these
results were very comparable with the previous study which
reported that incorporation of zinc content4 1.2 % wt can
lead to cytotoxic impacts on osteoblastic MC3T3-E1 cells
[28], in the present study Zn composed about 1 % wt of the
total glass weight in ZnO15 samples which could be due to
the difference in cell type.
5 Conclusion
The present study showed that adding zinc to the phosphate
based glass can be prepared successfully and displayed
acceptable outcomes concerning cellular metabolic activ-
ities. However the increase in zinc oxide concentration to
15 mol % may have cytotoxic effects, adding zinc oxide in
the percentage of 5–10 mol% may show acceptable effects
when compared it with the control sample.
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